editorial | Q871232 |
scholarly article | Q13442814 |
P50 | author | Kevin S Harrod | Q58020854 |
P2093 | author name string | Kevin S Harrod | |
P2860 | cites work | Animal models for Ebola and Marburg virus infections | Q21131118 |
Mucosal immunization of cynomolgus macaques with the VSVDeltaG/ZEBOVGP vaccine stimulates strong ebola GP-specific immune responses | Q21562420 | ||
Emergence of Zaire Ebola Virus Disease in Guinea | Q25197990 | ||
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial | Q27860949 | ||
Bats are natural reservoirs of SARS-like coronaviruses | Q28274751 | ||
Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia | Q29618053 | ||
Molecular determinants of Ebola virus virulence in mice | Q33250567 | ||
Preliminary report: isolation of Ebola virus from monkeys imported to USA. | Q33845982 | ||
Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys | Q33974706 | ||
Chimpanzee adenovirus vaccine protects against Zaire Ebola virus | Q33992247 | ||
Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study | Q34022606 | ||
Lethal experimental infections of rhesus monkeys by aerosolized Ebola virus | Q34057893 | ||
Epidemiology of Ebola (subtype Reston) virus in the Philippines, 1996. | Q34068510 | ||
Ebola--a growing threat? | Q34419216 | ||
??? | Q24596042 | ||
Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp | Q34426585 | ||
Studying "secret serums"--toward safe, effective Ebola treatments | Q34664019 | ||
The Ebola virus VP35 protein functions as a type I IFN antagonist. | Q35422223 | ||
Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection | Q35843254 | ||
Ebola virus: a comparison, at ultrastructural level, of the behaviour of the Sudan and Zaire strains in monkeys | Q36091078 | ||
Discovery and early development of AVI-7537 and AVI-7288 for the treatment of Ebola virus and Marburg virus infections | Q36432717 | ||
Interferon-β therapy prolongs survival in rhesus macaque models of Ebola and Marburg hemorrhagic fever | Q36936330 | ||
Immune parameters correlate with protection against ebola virus infection in rodents and nonhuman primates | Q37213207 | ||
Chronological and spatial analysis of the 1996 Ebola Reston virus outbreak in a monkey breeding facility in the Philippines | Q39253576 | ||
The pathology of experimental Ebola virus infection in monkeys | Q39634731 | ||
Ebola in a stew of fear | Q40190669 | ||
Filovirus tropism: cellular molecules for viral entry | Q40295070 | ||
Recombinant human activated protein C for the postexposure treatment of Ebola hemorrhagic fever | Q40433076 | ||
Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury | Q40616926 | ||
Experimental infection of cynomolgus macaques with Ebola-Reston filoviruses from the 1989-1990 U.S. epizootic | Q40674932 | ||
Experimental study of Ebola hemorrhagic fever in baboon models | Q40680378 | ||
Pathogenic potential of filoviruses: role of geographic origin of primate host and virus strain | Q40728062 | ||
A comparative study of strains of ebola virus isolated from southern sudan and northern zaire in 1976 | Q40864980 | ||
CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation | Q42246598 | ||
Seroepidemiological study of filovirus related to Ebola in the Philippines | Q44088838 | ||
A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever | Q44089779 | ||
Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques | Q48015946 | ||
Pathologic features of filovirus infections in humans | Q64132395 | ||
P433 | issue | 4 | |
P921 | main subject | Orthoebolavirus zairense | Q10538943 |
emerging pathogen | Q108429945 | ||
P304 | page(s) | L307-13 | |
P577 | publication date | 2014-12-12 | |
P1433 | published in | American Journal of Physiology - Lung Cellular and Molecular Physiology | Q4352992 |
P1476 | title | Ebola: history, treatment, and lessons from a new emerging pathogen | |
P478 | volume | 308 |
Q40049253 | Knowledge and attitudes of community volunteers on Lassa and Ebola viral haemorrhagic fevers in the Donga Department (North Benin) | cites work | P2860 |
Search more.